These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 31695329)

  • 1. In-vitro blood-brain barrier models for drug screening and permeation studies: an overview.
    Bagchi S; Chhibber T; Lahooti B; Verma A; Borse V; Jayant RD
    Drug Des Devel Ther; 2019; 13():3591-3605. PubMed ID: 31695329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-Brain Barrier (BBB)-Crossing Strategies for Improved Treatment of CNS Disorders.
    Zhang W
    Handb Exp Pharmacol; 2024; 284():213-230. PubMed ID: 37528323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting the blood-brain barrier: A hard nut to crack in the transportation of drug molecules.
    Harilal S; Jose J; Parambi DGT; Kumar R; Unnikrishnan MK; Uddin MS; Mathew GE; Pratap R; Marathakam A; Mathew B
    Brain Res Bull; 2020 Jul; 160():121-140. PubMed ID: 32315731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The barrier and interface mechanisms of the brain barrier, and brain drug delivery.
    Zhang S; Gan L; Cao F; Wang H; Gong P; Ma C; Ren L; Lin Y; Lin X
    Brain Res Bull; 2022 Nov; 190():69-83. PubMed ID: 36162603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-brain barrier structure and function and the challenges for CNS drug delivery.
    Abbott NJ
    J Inherit Metab Dis; 2013 May; 36(3):437-49. PubMed ID: 23609350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress and new challenges in modeling of human pluripotent stem cell-derived blood-brain barrier.
    Yan L; Moriarty RA; Stroka KM
    Theranostics; 2021; 11(20):10148-10170. PubMed ID: 34815809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro models of the blood-brain barrier.
    Wilhelm I; Fazakas C; Krizbai IA
    Acta Neurobiol Exp (Wars); 2011; 71(1):113-28. PubMed ID: 21499332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration.
    Heymans M; Sevin E; Gosselet F; Lundquist S; Culot M
    Eur J Pharm Biopharm; 2018 Jun; 127():453-461. PubMed ID: 29602020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Human Immortalized Cell-Based Blood-Brain Barrier Triculture Model: Development and Characterization as a Promising Tool for Drug-Brain Permeability Studies.
    Ito R; Umehara K; Suzuki S; Kitamura K; Nunoya KI; Yamaura Y; Imawaka H; Izumi S; Wakayama N; Komori T; Anzai N; Akita H; Furihata T
    Mol Pharm; 2019 Nov; 16(11):4461-4471. PubMed ID: 31573814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?
    Sanchez-Covarrubias L; Slosky LM; Thompson BJ; Davis TP; Ronaldson PT
    Curr Pharm Des; 2014; 20(10):1422-49. PubMed ID: 23789948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CNS drug delivery systems: novel approaches.
    Pathan SA; Iqbal Z; Zaidi SM; Talegaonkar S; Vohra D; Jain GK; Azeem A; Jain N; Lalani JR; Khar RK; Ahmad FJ
    Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):71-89. PubMed ID: 19149731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction.
    Engelhardt B; Sorokin L
    Semin Immunopathol; 2009 Nov; 31(4):497-511. PubMed ID: 19779720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nano carriers for drug transport across the blood-brain barrier.
    Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
    J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in blood-brain barrier disruption as a CNS delivery strategy.
    Bellavance MA; Blanchette M; Fortin D
    AAPS J; 2008; 10(1):166-77. PubMed ID: 18446517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in microphysiological blood-brain barrier (BBB) models towards drug delivery.
    Lee CS; Leong KW
    Curr Opin Biotechnol; 2020 Dec; 66():78-87. PubMed ID: 32711361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug penetration across the blood-brain barrier: an overview.
    Mangas-Sanjuan V; González-Alvarez M; Gonzalez-Alvarez I; Bermejo M
    Ther Deliv; 2010 Oct; 1(4):535-62. PubMed ID: 22833966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-brain barrier: structural components and function under physiologic and pathologic conditions.
    Persidsky Y; Ramirez SH; Haorah J; Kanmogne GD
    J Neuroimmune Pharmacol; 2006 Sep; 1(3):223-36. PubMed ID: 18040800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: trends and advances.
    Goyal K; Koul V; Singh Y; Anand A
    Cent Nerv Syst Agents Med Chem; 2014; 14(1):43-59. PubMed ID: 25360772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-brain-barrier organoids for investigating the permeability of CNS therapeutics.
    Bergmann S; Lawler SE; Qu Y; Fadzen CM; Wolfe JM; Regan MS; Pentelute BL; Agar NYR; Cho CF
    Nat Protoc; 2018 Dec; 13(12):2827-2843. PubMed ID: 30382243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle- and liposome-carried drugs: new strategies for active targeting and drug delivery across blood-brain barrier.
    Pinzón-Daza ML; Campia I; Kopecka J; Garzón R; Ghigo D; Riganti C
    Curr Drug Metab; 2013 Jul; 14(6):625-40. PubMed ID: 23869808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.